![Antonella Favit-van Pelt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antonella Favit-van Pelt
Fondateur chez
Synaerion Therapeutics, Inc.
Profil
Antonella Favit-van Pelt is the founder of Thera Neuropharma, Inc., founded in 2013.
Dr. Favit-van Pelt is the founder of Synaerion Therapeutics, Inc., founded in 2013, and holds the title of Chairman & President since 2017.
Dr. Favit-van Pelt was the founder of Stratmedica, LLC, founded in 2009, and held the title of Principal from 2009 to 2016.
Former jobs include Director-Medical Strategy at Bristol-Myers Squibb Pharma Research Labs LLC from 2005 to 2007, Senior Director at Shire Pharmaceuticals, Inc. from 2007 to 2008, Head-Medical Affairs at American Regent, Inc., Head-US Medical Strategy for Neurology at Lundbeck LLC, and Chief Medical Officer at Solana Co. from 2021 to 2026.
Education includes undergraduate and doctorate degrees from the University of Catania.
Postes actifs de Antonella Favit-van Pelt
| Sociétés | Poste | Début |
|---|---|---|
Synaerion Therapeutics, Inc. | Fondateur | 01/01/2013 |
Anciens postes connus de Antonella Favit-van Pelt
| Sociétés | Poste | Fin |
|---|---|---|
| SOLANA COMPANY | Directeur Technique/Scientifique/R&D | 08/04/2026 |
Lundbeck LLC
 Lundbeck LLC Pharmaceuticals: MajorHealth Technology Develops and provides specialty therapies for people with disorders of the central nervous system | Corporate Officer/Principal | 01/03/2021 |
American Regent, Inc.
 American Regent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes injectable drugs & intravenous iron therapies | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Stratmedica, LLC | Fondateur | 01/01/2016 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2008 |
Formation de Antonella Favit-van Pelt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Solana Co.
 Solana Co. Medical SpecialtiesHealth Technology Operates as a medical technology company focused on neurological wellness | Health Technology |
Bristol-Myers Squibb Pharma Research Labs LLC
 Bristol-Myers Squibb Pharma Research Labs LLC Miscellaneous Commercial ServicesCommercial Services Researches & develops drugs and related pharmaceutical products | Commercial Services |
American Regent, Inc.
American Regent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes injectable drugs & intravenous iron therapies | Health Technology |
University of Catania
 University of Catania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lundbeck LLC
Lundbeck LLC Pharmaceuticals: MajorHealth Technology Develops and provides specialty therapies for people with disorders of the central nervous system | Health Technology |
Synaerion Therapeutics, Inc. | |
Thera Neuropharma, Inc.
 Thera Neuropharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Stratmedica, LLC |
Choisissez Zonebourse 
